Jeff Clemetson
Reporter
Recent Stories
Poseida Inks $110M Deal With Roche
PHARMA: ‘Huge’ News in Cell Therapy
Poseida Therapeutics, Inc.’s gene and cell therapy technology has been given “validation” by Big Pharma. On Aug. 3, the company announced it had entered into a broad strategic collaboration and license agreement with Roche worth a potential $6 billion.
Good Peeps Sets Out to Unlock ‘Dormant Goodwill’
TECH: QR Code Stickers Help People Return Lost Items
Michael Fairclough is a believer in the ‘better angels’ of human nature. Two years ago, he founded Good Peeps, a digital platform that gives people who find lost items a way to return them.
Ingenium Expands Services, Markets
WASTE MANAGEMENT: Company Projecting 50% Revenue Growth
It’s been a year of growth for Ingenium. The Escondido-based firm has added new revenue, new employees, new markets and new services.
PSYONIC Brings Advanced Bionics to San Diego
MEDTECH: Firm Taps into Local Military, Tech, Medical Sectors
PSYONIC, maker of the world’s most advanced bionic hand, is now headquartered in America’s Finest City.
OrPro Therapeutics Lands ‘Difficult to Get’ DoD Grant
LIFE SCIENCE: Award to Fund Viral Lung Disease Therapy Research
The U.S. Department of Defense believes that San Diego-based OrPro Therapeutics, Inc. may have a way to help soldiers breathe easier.
Persephone Lands $15M Seed for Microbiome Platform
BIOTECH: Pipeline Includes Therapies for Infants, Cancer Patients
Persephone Biosciences Inc. CEO Stephanie Culler is on a mission to “unlock what the microbiome is doing and use it to reprogram human health.”
Replay Launches With $55M Seed Round
BIOTECH: Company Expanding Genomic Medicine Capabilities
Replay, a biotech firm with dual headquarters in San Diego and London, has emerged from stealth with $55 million in seed financing to advance its platform for writing genomics and reprogramming biology.
Veriteque Awarded Walmart Open Call Deal
TECHNOLOGY: At-Home Drug Test Kits Use Safe Chemistry
Veriteque, Inc. is poised to bring its powerful narcotics field tests used by police to homes across the country.
Cordial Closes $50M Series C
SaaS: Firm Growing B2C Platform
Cordial is preparing to disrupt the business-to-consumer marketing industry – but, as their name suggests, in a nice way.
Cibus Ready to Grow With Gene-Edited Seeds
BIOTECH: Company to Ship First Products
Cibus, a San Diego-based biotech specializing in gene-editing traits into crop seeds, is sprouted and ready to grow.
